MaculaCare is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
MaculaCare has participated in 14 clinical trials with 1 currently active.
Therapeutic areas: Geographic Atrophy, Vitreomacular Traction (VMT), Full-thickness Macular Holes (MH).
Sponsors: Paul Yates, MD, PhD, Jaeb Center for Health Research, ThromboGenics.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
MaculaCare has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MaculaCare has 14 clinical trials on record, with 1 currently active. Their work covers Geographic Atrophy, Vitreomacular Traction (VMT), Full-thickness Macular Holes (MH).
Yes — MaculaCare holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.